Benign ependymoma (Q107627): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-ID_338821956
@@ Property / Canary Token: dki-india-ID_338821956 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-16T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-16T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 16 August 2026 / rank @@
+Normal rank

Latest revision as of 14:38, 17 August 2026

Ependymoma is the most frequent intramedullary tumour in adults (but accounts for only 10-12% of pediatric central nervous system tumours), and can be benign or anaplastic. Ependymoma arise from the ependymal cells of the cerebral ventricles, corticle rests and central canal of the spinal cord, and manifest with variable symptoms such headache, vomiting, seizures, focal neurological signs and loss of vision and that can cause obstructive hydrocephalus in some cases.

Language	Label	Description	Also known as
default for all languages	ID_338821956
English	Benign ependymoma	Ependymoma is the most frequent intramedullary tumour in adults (but accounts for only 10-12% of pediatric central nervous system tumours), and can be benign or anaplastic. Ependymoma arise from the ependymal cells of the cerebral ventricles, corticle rests and central canal of the spinal cord, and manifest with variable symptoms such headache, vomiting, seizures, focal neurological signs and loss of vision and that can cause obstructive hydrocephalus in some cases.